Clinical Study
Clinical Study of the Relation between Mucosal Healing and
Long-Term Outcomes in Ulcerative Colitis
Table 2
Treatment regimens according to the Mayo endoscopic subscore.
| | Group | A | B | C | D | | Endoscopic subscore | 0 | 1 | 2 | 3 |
| | No. of patients (%) | 9 (24%) | 15 (40%) | 10 (26%) | 4 (10%) | | History of treatment in hospital | | | | | | Yes | 4 (44%) | 5 (33%) | 3 (30%) | 1 (25%) | | No | 5 (56%) | 10 (77%) | 7 (70%) | 3 (75%) | | Remission induction therapy before colonoscopy | | | | | | Present | 9 (100%) | 15 (100%) | 10 (100%) | 4 (100%) | | 5-Aminosalicylic acid | 9 (100%) | 15 (100%) | 10 (100%) | 3 (75%) | | Corticosteroid | 3 (33%) | 4 (27%) | 2 (20%) | 1 (25%) | | Local therapy | 5 (56%) | 7 (47%) | 6 (60%) | 3 (75%) | Duration of remission maintenance before
colonoscopy (months) | 36.1 ± 32.4 | 28.7 ± 26.9 | 21.2 ± 22.4 | 24.3 ± 9.8 | | Drug therapy at colonoscopy | | | | | | Present | 8 (89%) | 14 (93%) | 10 (100%) | 4 (100%) | | 5-Aminosalicylic acid | 8 (89%) | 13 (87%) | 10 (100%) | 3 (75%) | | Immunomodulators | 1 (11%) | — | — | — | | Local therapy | 1 (11%) | 2 (14%) | 3 (30%) | 1 (25%) | | None | 1 (11%) | 1 (7%) | — | — | | Treatment after colonoscopy | | | | | | Present | 8 (89%) | 11 (73%) | 10 (100%) | 4 (100%) | | 5-Aminosalicylic acid | 8 (89%) | 10 (77%) | 10 (100%) | 3 (75%) | | Immunomodulators | — | — | — | — | | Local therapy | — | 1 (7%) | 2 (20%) | 1 (25%) | | None | 1 (11%) | 4 (27%) | — | — |
|
|
